Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07306338

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

This study assesses patient perspectives on the interest in, feasibility, and acceptability of an Integrative Oncology Program for patients at USC NCCC and HC3 Women's Clinic.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

USC / Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

Location status: Recruiting

Location contact

Xiaoyue M. Guo

CONTACT

[email protected]

323-409-3422

Xiaoyue M. Guo

PRINCIPAL_INVESTIGATOR

About this study

PRIMARY OBJECTIVE:

I. To measure patient knowledge, attitudes, and interest in IO program services, identify predictors of willingness to participate or refer, and potential barriers to implementation into existing clinical care workflows.

OUTLINE: This is an observational study.

Patients complete a survey and may participate in a focus group on study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Ability to understand and the willingness to participate in the study.
  • English, Spanish, or Chinese speaking
  • Patient of USC NCCC Outpatient Clinics or Keck HC3 Women's Health outpatient clinic.
  • Diagnosed solid or hematologic Malignancy

Exclusion criteria

  • Unable to provide informed consent

Treatment and study plan

Non-Interventional Study

Other

Non-interventional study

Other names: Non-Interventional Observational Study, Noninterventional (Observational) Study

Primary outcomes

  1. Patient knowledge about Integrative Oncology (IO) program services

    Time frame: Through study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.

  2. Patient attitudes about IO program services

    Time frame: Through study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.

  3. Patient interest in IO program services

    Time frame: Through study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.

  4. Predictors of willingness to participate or refer

    Time frame: Through study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. Adapted survey items from previously published studies (Larbi et al. 2021; Mao et al. 2014), including willingness to participate and pay will be used to asses this outcome.

  5. Potential barriers to implementation

    Time frame: Through study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.

Sponsors and collaborators

Lead sponsor

University of Southern California

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2028
First posted
Dec 29, 2025
Registry last updated
Mar 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.